HCAT - Health Catalyst, Inc.
NASDAQ
->
Healthcare
->
Health Information Services
South Jordan,
United States
Type: Equity
HCAT price evolution
HCAT
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $201.9 | $201.37 | $106.28 | |
| Short term investments | $106.36 | $126.42 | $211.45 | |
| Net receivables | $51.65 | $54.9 | $53.87 | $60.29 |
| Inventory | ||||
| Total current assets | $457.41 | $376.07 | $397.14 | $393.4 |
| Long term investments | ||||
| Property, plant & equipment | $39.13 | $37.18 | $36.7 | $39.64 |
| Goodwill & intangible assets | $273.06 | $256.87 | $264.04 | |
| Total noncurrent assets | $315.65 | $297.98 | $308.42 | |
| Total investments | $106.36 | $126.42 | $211.45 | |
| Total assets | $813.05 | $691.72 | $695.11 | $701.81 |
| Current liabilities | ||||
| Accounts payable | $14.28 | $10.6 | $5.7 | $6.64 |
| Deferred revenue | $56.41 | $63.63 | $55.83 | |
| Short long term debt | $232.13 | $3.35 | $3.36 | |
| Total current liabilities | $323.78 | $318.02 | $92.21 | $89.03 |
| Long term debt | $114.61 | $16.54 | $245.53 | $245.71 |
| Total noncurrent liabilities | $16.69 | $245.69 | $245.86 | |
| Total debt | $248.67 | $248.87 | $249.07 | |
| Total liabilities | $458.01 | $334.72 | $337.9 | $334.89 |
| Shareholders' equity | ||||
| Retained earnings | -$1166 | -$1151.27 | -$1137.76 | -$1117.17 |
| Other shareholder equity | -$0.11 | -$0.16 | -$0.12 | $0.03 |
| Total shareholder equity | $357 | $357.21 | $366.92 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $106.28 | $116.31 | $193.23 | $91.95 |
| Short term investments | $211.45 | $247.18 | $251.75 | $178.92 |
| Net receivables | $60.29 | $47.97 | $48.8 | $48.3 |
| Inventory | ||||
| Total current assets | $393.4 | $427.8 | $508.39 | $329.8 |
| Long term investments | ||||
| Property, plant & equipment | $39.64 | $42.59 | $44.45 | $37.59 |
| Goodwill & intangible assets | $264.04 | $278.17 | $274.76 | $206.74 |
| Total noncurrent assets | $308.42 | $324.49 | $323.7 | $247.94 |
| Total investments | $211.45 | $247.18 | $251.75 | $178.92 |
| Total assets | $701.81 | $752.29 | $832.1 | $577.74 |
| Current liabilities | ||||
| Accounts payable | $6.64 | $4.42 | $4.69 | $5.33 |
| Deferred revenue | $55.83 | $55.07 | $57.56 | $49.02 |
| Short long term debt | $3.36 | $3.43 | $3.42 | $2.62 |
| Total current liabilities | $89.03 | $82.51 | $93.05 | $88.04 |
| Long term debt | $245.71 | $226.52 | $201.19 | $192.66 |
| Total noncurrent liabilities | $245.86 | $244.77 | $216.95 | $213.6 |
| Total debt | $249.07 | $247.97 | $204.61 | $195.28 |
| Total liabilities | $334.89 | $327.28 | $310 | $301.64 |
| Shareholders' equity | ||||
| Retained earnings | -$1117.17 | -$999.02 | -$878.86 | -$725.65 |
| Other shareholder equity | $0.03 | -$0.65 | -$0.07 | $0.06 |
| Total shareholder equity | $366.92 | $425.01 | $522.1 | $276.1 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $76.35 | $75.9 | $74.72 | $75.08 |
| Cost of revenue | $40.06 | $38.52 | $44.58 | |
| Gross Profit | $34.24 | $35.84 | $36.21 | $30.51 |
| Operating activities | ||||
| Research & development | $13.88 | $14.87 | $20.29 | |
| Selling, general & administrative | $27.11 | $33.62 | $32.7 | |
| Total operating expenses | $46.44 | $51.65 | $59.02 | $63.29 |
| Operating income | -$15.81 | -$22.81 | -$32.78 | |
| Income from continuing operations | ||||
| EBIT | -$13.45 | -$20.47 | -$32.78 | |
| Income tax expense | -$0.47 | $0.07 | $0.11 | $0.14 |
| Interest expense | -$1.39 | -$2.62 | ||
| Net income | ||||
| Net income | -$14.73 | -$13.52 | -$20.59 | -$30.31 |
| Income (for common shares) | -$13.52 | -$20.59 | -$30.31 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $295.94 | $276.24 | $241.93 | $188.84 |
| Cost of revenue | $164.1 | $143.05 | $124.35 | $98.08 |
| Gross Profit | $131.83 | $133.19 | $117.57 | $90.77 |
| Operating activities | ||||
| Research & development | $72.63 | $75.68 | $62.73 | $53.52 |
| Selling, general & administrative | $143.88 | $149.22 | $160.96 | $114.65 |
| Total operating expenses | $258.73 | $273.19 | $261.22 | $186.89 |
| Operating income | -$126.9 | -$140 | -$143.65 | -$96.13 |
| Income from continuing operations | ||||
| EBIT | -$126.9 | -$140 | -$143.65 | -$104.64 |
| Income tax expense | $0.36 | -$4.28 | -$6.9 | -$1.19 |
| Interest expense | -$9.11 | $1.68 | $16.46 | $11.57 |
| Net income | ||||
| Net income | -$118.15 | -$137.4 | -$153.21 | -$115.02 |
| Income (for common shares) | -$118.15 | -$137.4 | -$153.21 | -$115.02 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$13.52 | -$20.59 | -$30.31 | |
| Operating activities | ||||
| Depreciation | $11.31 | $11.31 | $11.02 | |
| Business acquisitions & disposals | -$18.66 | -$11.39 | ||
| Stock-based compensation | $8.97 | $10.84 | $13.01 | |
| Total cash flows from operations | $1.61 | $10.27 | -$19.04 | |
| Investing activities | ||||
| Capital expenditures | -$4.04 | -$2.73 | -$2.87 | |
| Investments | $21.2 | $86.8 | $44.31 | |
| Total cash flows from investing | $89.85 | -$1.78 | $83.98 | $29.92 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.7 | $0.86 | $0.4 | |
| Net borrowings | ||||
| Total cash flows from financing | $114.06 | $0.7 | $0.86 | $0.4 |
| Effect of exchange rate | $0.06 | -$0 | -$0.02 | $0.03 |
| Change in cash and equivalents | $222.05 | $0.53 | $95.09 | $11.3 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$118.15 | -$137.4 | -$153.21 | -$115.02 |
| Operating activities | ||||
| Depreciation | $45.21 | $51.53 | $41.11 | $23.03 |
| Business acquisitions & disposals | -$11.39 | -$27.85 | -$46.76 | -$101.66 |
| Stock-based compensation | $55.76 | $72.1 | $65.14 | $37.96 |
| Total cash flows from operations | -$33.08 | -$35.27 | -$23.12 | -$26.15 |
| Investing activities | ||||
| Capital expenditures | -$13.16 | -$15.13 | -$17.07 | -$9.2 |
| Investments | $45.97 | $6.21 | -$74.47 | $29.54 |
| Total cash flows from investing | $20.29 | -$39.02 | -$139.68 | -$82.56 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $2.73 | -$1.27 | $270.37 | $40.54 |
| Net borrowings | $143.7 | |||
| Total cash flows from financing | $2.73 | -$2.61 | $264.08 | $182.61 |
| Effect of exchange rate | $0.02 | -$0.01 | -$0.01 | $0.03 |
| Change in cash and equivalents | -$10.04 | -$76.92 | $101.27 | $73.92 |
News
Fundamentals
| Market cap | $329.79M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 60.85M |
| Revenue | $302.06M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$79.14M |
| Revenue Q/Q | 3.50% |
| Revenue Y/Y | 4.15% |
| P/E ratio | -4.17 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 1.09 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$1.30 |
|---|---|
| ROA | -10.91% |
| ROE | N/A |
| Debt/Equity | 0.91 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.41 |
| Quick ratio | N/A |